Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVEC.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 4, p. 200, doi. 10.1002/hon.2005
- By:
- Publication type:
- Article
Works by Volchek, Yulia
Results: 8
1
2
Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 6, p. 863, doi. 10.1002/cncr.29141
- By:
- Publication type:
- Article
3
Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
4
A Nationwide Observational Study of Ponatinib in CML Patients Outside of Clinical Trials- The Israeli Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S64, doi. 10.1016/j.clml.2016.07.093
- By:
- Publication type:
- Article
5
Nilotinib-associated acute pancreatitis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
6
Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 3, p. 375, doi. 10.1007/s00277-014-2229-3
- By:
- Publication type:
- Article
7
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 8, p. 1297, doi. 10.1007/s00277-014-2043-y
- By:
- Publication type:
- Article
8
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article